Name of the Procedure:

Common Name: Amantadine Hydrochloride Treatment
Medical Term: G9017 Amantadine Hydrochloride, Oral, Per 100 mg (for use in a Medicare-approved demonstration project)

Summary

Amantadine Hydrochloride is an oral medication used in specific medicinal projects approved by Medicare. It falls under the HCPCS code G9017 and is prescribed for various medical conditions, including Parkinson’s disease and drug-induced extrapyramidal reactions.

Purpose

Medical Conditions/Problems Addressed:

• Parkinson’s disease
• Drug-induced extrapyramidal reactions
• Influenza A virus prophylaxis and treatment

Goals/Expected Outcomes:

• Alleviation of motor symptoms in Parkinson’s patients
• Reduction of involuntary movements caused by other medications
• Prevention and treatment of influenza A virus

Indications

Symptoms/Conditions Warranting Procedure:

• Motor control issues such as tremors and stiffness in Parkinson’s patients
• Uncontrolled movements due to certain antipsychotic medications
• High risk or presence of influenza A infection

Patient Criteria:

• Diagnosed with Parkinson’s disease or experiencing drug-induced extrapyramidal symptoms
• Fit for participating in a Medicare-approved demonstration project

Preparation

Pre-Procedure Instructions:

• There usually aren't specific fasting or physical preparations required before starting this medication.
• Patients should inform their healthcare provider about current medications and medical history.

Diagnostic Tests/Assessments:

• Comprehensive medical evaluation
• Potential blood tests or other diagnostics to rule out contraindications

Procedure Description

Step-by-Step Explanation:

1. Prescription: A healthcare provider evaluates the patient and prescribes Amantadine Hydrochloride as appropriate.
2. Administration: The medication is taken orally, with the dosage often starting at 100 mg daily.
3. Monitoring: Regular follow-ups to monitor effectiveness and side effects.

Tools, Equipment, or Technology Used:

• Oral medication (tablet or liquid form)

Anesthesia/Sedation Details:

• Not applicable, as this is an oral medication.

Duration

Duration of the Procedure:

• The prescription and initial evaluation might take 30-60 minutes.
• The medication’s effectiveness and usage might necessitate long-term administration.

Setting

Where Performed:

• Outpatient settings such as clinics or physician offices

Personnel

Healthcare Professionals Involved:

• Primary Care Physicians
• Neurologists
• Pharmacists

Risks and Complications

Common Risks:

• Nausea, dizziness, and insomnia
• Dry mouth and loss of appetite

Rare Risks:

• Hallucinations
• Heart failure and arrhythmias

Management of Complications:

• Immediate consultation with the prescribing physician for any severe or persistent side effects

Benefits

Expected Benefits:

• Improved control over Parkinsonian symptoms and reduced involuntary movements
• Quick relief from initial symptoms could be seen within a few days to weeks.

Recovery

Post-Procedure Care/Instructions:

• Regular intake as prescribed
• Attend follow-up appointments for monitoring

Expected Recovery Time:

• Ongoing management with periodic reassessment

Restrictions and Follow-Up:

• Potential adjustment of dosages based on patient response

Alternatives

Other Treatment Options:

• Other Parkinson’s medications (e.g., Levodopa)
• Non-pharmacological therapies like physical therapy

Pros and Cons of Alternatives:

• Other medications may have different side effect profiles.
• Physical therapy can complement but might not replace pharmacotherapy for some conditions.

Patient Experience

During the Procedure:

• Patients will need to take medication as prescribed.

After the Procedure:

• Possible side effects like mild nausea or dizziness.
• Pain management and comfort measures typically aren't necessary as it’s an oral medication but monitoring and managing side effects with professional guidance is crucial.